The binding energy for the interaction between spiperone and FGFBP1 was −6.63 kcal/mol, indicating a strong binding affinity (Figure 10), supporting its potential as a therapeutic compound for CRSwNP. This evidence concerns the gene FGFBP1 and chronic rhinosinusitis with nasal polyps.